High-risk smoldering myeloma (HR-SMM) is a significant phase within the spectrum of plasma cell disorders, situated between monoclonal gammopathy of undetermined significance (MGUS) and active multiple myeloma (MM). Although individuals with HR-SMM often do not exhibit any clinical symptoms, they are at a markedly increased risk of advancing to symptomatic myeloma. Understanding this critical...
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian